Rigel Pharmaceuticals
RIGL
RIGL
118 hedge funds and large institutions have $143M invested in Rigel Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 46 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
30% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 46
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Holders
118
Holding in Top 10
–
Calls
$1.13M
Puts
$122K
Top Buyers
| 1 | +$4.34M | |
| 2 | +$2.99M | |
| 3 | +$1.77M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.11M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$788K |
Top Sellers
| 1 | -$3.4M | |
| 2 | -$2.41M | |
| 3 | -$1.17M | |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$968K |
| 5 |
Millennium Management
New York
|
-$956K |